STOCK TITAN

Verastem Oncology to Present at the Jefferies London Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Verastem Oncology (NASDAQ: VSTM) announced its participation in the Jefferies London Healthcare Conference, with an on-demand presentation available starting November 18, 2021, at 8:00 a.m. GMT (3:00 a.m. ET). A webcast will be accessible via the company's investor website, and an archived version will be available for 30 days. Verastem is dedicated to developing new cancer therapies, focusing on small molecule drugs that inhibit key signaling pathways critical for tumor growth and cell survival.

Positive
  • None.
Negative
  • None.

BOSTON--(BUSINESS WIRE)-- Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced that the Company will present at the Jefferies London Healthcare Conference. The presentation will be made available for on-demand listening beginning Thursday, November 18, 2021 at 8:00 a.m. GMT (3:00 a.m. ET).

A webcast of the presentation will be available on investors section of the Company’s website at www.verastem.com. An archived presentation will be made available for 30 days.

About Verastem Oncology

Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and FAK inhibition. For more information, please visit www.verastem.com.

Investors:

Ajay Munshi

Vice President, Corporate Development

+1 781-469-1579

amunshi@verastem.com

Sherri Spear

Argot Partners

+1 212-600-1902

sherri@argotpartners.com

Media:

Lisa Buffington

Corporate Communications

+1 781-292-4205

lbuffington@verastem.com

Source: Verastem Oncology

FAQ

What is Verastem Oncology's stock symbol?

Verastem Oncology's stock symbol is VSTM.

When will Verastem's presentation at the Jefferies London Healthcare Conference be available?

The presentation will be available on-demand starting November 18, 2021, at 8:00 a.m. GMT.

Where can I watch Verastem's presentation?

You can watch the presentation on Verastem's investor website.

How long will Verastem's presentation be available for viewing?

The archived presentation will be available for 30 days.

What is the focus of Verastem Oncology's research?

Verastem Oncology focuses on developing small molecule drugs that inhibit critical cancer signaling pathways.

Verastem, Inc.

NASDAQ:VSTM

VSTM Rankings

VSTM Latest News

VSTM Stock Data

162.99M
44.51M
0.83%
35.94%
6.06%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
NEEDHAM